{"database":"NODE","file_versions":[],"scores":null,"additional":{"omics_type":["Transcriptomics"],"submitter":["Jiexian Ma"],"technology_type":["RNA-Seq"],"experiment_platform":["Illumina HiSeq 2000"],"full_dataset_link":["https://www.biosino.org/node/experiment/detail/OEX00014403"],"experiment_library_selection":["RANDOM"],"experiment_library_layout":["Paired"],"sample_count":["1"],"tissue":["['blood Cell Line']"],"taxonomy":["['Homo sapiens']"],"repository":["NODE"],"additional_accession":[]},"is_claimable":false,"name":"OEX_Jiexian_2108201709","description":"To begin to elucidate the mechanism of action of decitabine with etoposide-based(D+E) treatment, we selected the TP53 mutation (THP-1 and U937) and TP53 WT (MOLM13) AML/MDS cell lines and treated them with etoposide or aclarubicin according to the indicated dose","dates":{"publication":"2021-08-21","submission":"2021-08-20"},"accession":"OEX00014403","cross_references":{"NODE":["OEP00002612"]}}